These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 16877656)

  • 21. Treatment of panic disorder with agoraphobia: randomized placebo-controlled trial of four psychosocial treatments combined with imipramine or placebo.
    Marchand A; Coutu MF; Dupuis G; Fleet R; Borgeat F; Todorov C; Mainguy N
    Cogn Behav Ther; 2008; 37(3):146-59. PubMed ID: 18608313
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influence of panic-agoraphobic spectrum symptoms on treatment response in patients with recurrent major depression.
    Frank E; Shear MK; Rucci P; Cyranowski JM; Endicott J; Fagiolini A; Grochocinski VJ; Houck P; Kupfer DJ; Maser JD; Cassano GB
    Am J Psychiatry; 2000 Jul; 157(7):1101-7. PubMed ID: 10873918
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A randomized effectiveness trial of collaborative care for patients with panic disorder in primary care.
    Roy-Byrne PP; Katon W; Cowley DS; Russo J
    Arch Gen Psychiatry; 2001 Sep; 58(9):869-76. PubMed ID: 11545671
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy of d-cycloserine for enhancing response to cognitive-behavior therapy for panic disorder.
    Otto MW; Tolin DF; Simon NM; Pearlson GD; Basden S; Meunier SA; Hofmann SG; Eisenmenger K; Krystal JH; Pollack MH
    Biol Psychiatry; 2010 Feb; 67(4):365-70. PubMed ID: 19811776
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Web-based therapist-assisted cognitive behavioral treatment of panic symptoms: a randomized controlled trial with a three-year follow-up.
    Ruwaard J; Broeksteeg J; Schrieken B; Emmelkamp P; Lange A
    J Anxiety Disord; 2010 May; 24(4):387-96. PubMed ID: 20227241
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A randomized clinical trial of cognitive behavioral therapy and interpersonal psychotherapy for panic disorder with agoraphobia.
    Vos SP; Huibers MJ; Diels L; Arntz A
    Psychol Med; 2012 Dec; 42(12):2661-72. PubMed ID: 22717019
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phenomenology and severity of major depression and comorbid lifetime anxiety disorders in primary medical care practice.
    Brown C; Schulberg HC; Shear MK
    Anxiety; 1996; 2(5):210-8. PubMed ID: 9160625
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CBT intensity and outcome for panic disorder in a primary care setting.
    Craske MG; Roy-Byrne P; Stein MB; Sullivan G; Hazlett-Stevens H; Bystritsky A; Sherbourne C
    Behav Ther; 2006 Jun; 37(2):112-9. PubMed ID: 16942966
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Unemployment and emergency room visits predict poor treatment outcome in primary care panic disorder.
    Roy-Byrne PP; Russo J; Cowley DS; Katon WJ
    J Clin Psychiatry; 2003 Apr; 64(4):383-9. PubMed ID: 12716237
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Defense mechanisms after brief cognitive-behavior group therapy for panic disorder: one-year follow-up.
    Heldt E; Blaya C; Kipper L; Salum GA; Otto MW; Manfro GG
    J Nerv Ment Dis; 2007 Jun; 195(6):540-3. PubMed ID: 17568304
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Is internet-based CBT for panic disorder and agoraphobia as effective as face-to-face CBT?
    Kiropoulos LA; Klein B; Austin DW; Gilson K; Pier C; Mitchell J; Ciechomski L
    J Anxiety Disord; 2008 Dec; 22(8):1273-84. PubMed ID: 18289829
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of cognitive-behavioral therapy for panic disorder on comorbidity: a controlled investigation.
    Tsao JC; Mystkowski JL; Zucker BG; Craske MG
    Behav Res Ther; 2005 Jul; 43(7):959-70. PubMed ID: 15896289
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The DSM-IV panic disorder field trial: panic attack frequency and functional disability.
    Fyer AJ; Katon W; Hollifield M; Rassnick H; Mannuzza S; Chapman T; Ballenger JC
    Anxiety; 1996; 2(4):157-66. PubMed ID: 9160617
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interoceptive hypersensitivity as prognostic factor among patients with panic disorder who have received cognitive behavioral therapy.
    Ogawa S; Furukawa TA; Nakano Y; Funayama T; Watanabe N; Noguchi Y; Sasaki M
    J Behav Ther Exp Psychiatry; 2010 Sep; 41(3):325-9. PubMed ID: 20381013
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term stability of cognitive behavioral therapy effects for panic disorder with agoraphobia: a two-year follow-up study.
    Gloster AT; Hauke C; Höfler M; Einsle F; Fydrich T; Hamm A; Sthröhle A; Wittchen HU
    Behav Res Ther; 2013 Dec; 51(12):830-9. PubMed ID: 24184430
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Randomized controlled trial of motivational interviewing, cognitive behavior therapy, and family intervention for patients with comorbid schizophrenia and substance use disorders.
    Barrowclough C; Haddock G; Tarrier N; Lewis SW; Moring J; O'Brien R; Schofield N; McGovern J
    Am J Psychiatry; 2001 Oct; 158(10):1706-13. PubMed ID: 11579006
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quality of care for primary care patients with anxiety disorders.
    Stein MB; Sherbourne CD; Craske MG; Means-Christensen A; Bystritsky A; Katon W; Sullivan G; Roy-Byrne PP
    Am J Psychiatry; 2004 Dec; 161(12):2230-7. PubMed ID: 15569894
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Predictors of clinical improvement in a randomized effectiveness trial for primary care patients with panic disorder.
    Chavira DA; Stein MB; Golinelli D; Sherbourne CD; Craske MG; Sullivan G; Bystritsky A; Roy-Byrne PP
    J Nerv Ment Dis; 2009 Oct; 197(10):715-21. PubMed ID: 19829198
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Panic disorder in primary care: biopsychosocial differences between recognized and unrecognized patients.
    Roy-Byrne PP; Katon W; Cowley DS; Russo JE; Cohen E; Michelson E; Parrot T
    Gen Hosp Psychiatry; 2000; 22(6):405-11. PubMed ID: 11072056
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adherence to treatment among economically disadvantaged patients with panic disorder.
    Mukherjee S; Sullivan G; Perry D; Verdugo B; Means-Christensen A; Schraufnagel T; Sherbourne CD; Stein MB; Craske MG; Roy-Byrne PP
    Psychiatr Serv; 2006 Dec; 57(12):1745-50. PubMed ID: 17158489
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.